Harbor Capital Advisors, Inc. Biogen Inc. Transaction History

Harbor Capital Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 20, 2023	SELL	$252.44 - $306.72 $38,370 - $46,621	-152 Reduced 36.19%	268 $0
Q3 2022 Oct 28, 2022	SELL	$194.69 - $268.46 $70,088 - $96,645	-360 Reduced 46.15%	420 $112,000
Q2 2022 Jul 26, 2022	SELL	$187.54 - $223.02 $1,125 - $1,338	-6 Reduced 0.76%	780 $159,000
Q1 2022 Apr 28, 2022	BUY	$193.77 - $244.14 $152,303 - $191,894	786 New	786 $166,000

1,032

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Harbor Capital Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbor Capital Advisors, Inc. with notifications on news.